Related Experiment Video
Updated: Apr 6, 2026
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
Short-term outcomes in patients with acute coronary syndrome treated with direct bioresorbable scaffold deployment
Ayyaz Sultan1, Varinder Randhawa1, Anthony C Camuglia1
1Division of Cardiology, Department of Internal Medicine, London Health Sciences Centre, Western University, London, Ontario, Canada.
Background:
Direct coronary stenting is a validated therapeutic option for coronary lesions. We studied the feasibility of direct deployment with a bioresorbable vascular scaffold (BVS) in acute coronary syndrome (ACS).
Methods:
Demographic, procedural, and survival data were obtained for patients who had direct scaffold deployment with BVS from 1 May 2013 to 1 April 2014.
Results:
We performed a retrospective review of nine patients which included eight patients having ST-elevation myocardial infarction. There were no cases of worsening coronary flow, scaffold thrombosis, target lesion revascularization or death up to 30 days post intervention.
Conclusion:
Direct BVS deployment in ACS appears safe and feasible.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies